Capital Markets

True Leaf in its $10.5 million convertible security financing

True Leaf Medicine International Ltd.
Expertise
Capital Markets
Team
Patrick J. Sullivan

Partner, Corporate, Vancouver

Trevor R. Scott

Partner, Corporate, Vancouver

Martha Martindale

Partner, Financial Services, Vancouver

Shahir Guindi, Ad. E.

Former National Co-Chair, Partner, Corporate, Montréal

Jason Comerford

Partner, Corporate, New York

On February 21, 2019, True Leaf Medicine International Ltd. ("True Leaf") announced that it closed a convertible security financing for gross proceeds of $4.5 million with an entity managed by The Lind Partners.  Under the funding agreement, True Leaf and the investor may agree for the investor to advance up to an additional $6 million in gross proceeds to True Leaf in exchange for a second convertible security on the same terms.

True Leaf Medicine International Ltd., headquartered in Vancouver, Canada, is a leading global cannabis and hemp wellness brand for pets.

The Lind Partners is a New York-based institutional fund manager focused on small- and mid-cap companies listed in the United States, Canada, Australia, and the UK focused on high-growth sectors such as mining, oil and gas, biotech, and technology.

Osler, Hoskin & Harcourt LLP represented True Leaf Medicine with a team consisting of Trevor Scott, Shahir Guindi, Jason Comerford, Patrick Sullivan (Corporate) and Martha Martindale (Financial Services).

Value
$10.5 million
Date Closed
February 21, 2019
Lead Office
Vancouver
Team
Patrick J. Sullivan

Partner, Corporate, Vancouver

Trevor R. Scott

Partner, Corporate, Vancouver

Martha Martindale

Partner, Financial Services, Vancouver

Shahir Guindi, Ad. E.

Former National Co-Chair, Partner, Corporate, Montréal

Jason Comerford

Partner, Corporate, New York